Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Clinical characteristics. by Guangquan An (11473126)

Pearson’s correlation showing significant correlations (<i>P</i> < 0.05) between microbiota and clinical variables in the Staph group. by Paulo Kussek (13410476)

Following supporting information attached to this manuscript: *Calculations of BMI changes before and after experiment by Tukey-Kramer’s inter group test; * Calculations of TP, Cho... by Fatima Dikhanbayeva (11501962)

Subjects:

Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

Clinical relapse rate after colonoscopy. by Yuriko Otake-Kasamoto (15314630)

Subjects:

Demographic & clinical characteristics of the sample. by David H. Rosmarin (16542340)

Subjects:

Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness). by Ann Logan (9361)

Reliable Change Index for the main clinical outcomes. by Blanca Rojas (419549)

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Clinical dates in coinfected Chagas/HIV patients. by Gláucia Elisete Barbosa Marcon (4746726)

Subjects:

Supplementary Material for: Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer by Izawa N. (6834062)

Gut and nasal microbiome features have significantly different pairwise distance distributions compared to null expectation. by Holly Kristin Arnold (14204655)

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Baseline clinical characteristics. by Thao H. P. Nguyen (11027765)

Table_2_The changes and its significance of peripheral blood NK cells in patients with tuberculous meningitis.DOCX by Jie Mi (152887)

“…The proportion of TBM patients (48.7%) with a lower absolute count of NK cells than the normal reference value was significantly higher than that in NC (5.2%) and LTBI groups (4.0%) (p < 0.05), and slightly higher than that in NSTB group (36.0%) (p > 0.05). …”

Table_1_The changes and its significance of peripheral blood NK cells in patients with tuberculous meningitis.DOCX by Jie Mi (152887)

“…The proportion of TBM patients (48.7%) with a lower absolute count of NK cells than the normal reference value was significantly higher than that in NC (5.2%) and LTBI groups (4.0%) (p < 0.05), and slightly higher than that in NSTB group (36.0%) (p > 0.05). …”